📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Advancing the chemotherapy of tuberculous meningitis: a consensus view. (2025)

First Author: Wasserman S

Attributed to: Short enhanced anti-tuberculosis and anti-thrombosis treatment for children with tuberculous meningitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00512-7

PubMed Identifier: 39342951

Publication URI: http://europepmc.org/abstract/MED/39342951

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet. Infectious diseases

Issue: 1

ISSN: 1473-3099